This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: F. Hoffmann-La Roche Ag. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Martin Olbrich: Innovator in Oligonucleotide Technology
Introduction
Martin Olbrich is a notable inventor based in Loerrach, Germany. He has made significant contributions to the field of biotechnology, particularly in the preparation of oligonucleotide products. His work is characterized by a focus on innovation and precision in scientific processes.
Latest Patents
Martin Olbrich holds a patent for a "Process for the preparation of spray dried oligonucleotide products with controlled humidity." This patent highlights his expertise in developing methods that enhance the quality and stability of oligonucleotide products, which are crucial in various applications, including pharmaceuticals and genetic research. He has 1 patent to his name.
Career Highlights
Olbrich is currently employed at F. Hoffmann-La Roche AG, a leading global healthcare company. His role involves research and development, where he applies his innovative ideas to advance the company's product offerings. His work has contributed to the company's reputation for excellence in the biotechnology sector.
Collaborations
Throughout his career, Martin has collaborated with esteemed colleagues, including Kurt Puentener and David Linder. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of their research.
Conclusion
Martin Olbrich is a distinguished inventor whose work in oligonucleotide technology has made a significant impact in the field of biotechnology. His innovative processes and collaborations with other experts continue to drive advancements in this important area of research.